IFPMA pharma code expandsApril 2012
The international pharmaceuticals industry’s code of conduct has been expanded. The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) code, which will now govern all interactions that member companies have with healthcare professionals, medical institutions and patient organisations, has bolstered its principles on employee training, bribery, clinical trials disclosure and complaints mechanisms.
Already a member? click here to login